Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Medical Crowdsourcing Helped Save Girl from Deadly E. Coli Strain That Killed Brother

This image opens in the lightbox

News provided by

SERMO

10 Aug, 2015, 07:00 GMT

Share this article

Share toX

Share this article

Share toX

- SERMO Expands Globally, Opening Medical Crowdsourcing to Doctors in Seven Countries

NEW YORK, Aug. 10, 2015 /PRNewswire/ -- This month, members of SERMO, the leading global social network exclusively for doctors and the home of medical crowdsourcing, helped save a girl's life through collaboration across borders. The infection she was diagnosed with had killed her brother just two weeks earlier. Because of SERMO's recent expansion to the UK, Canada, Australia, South Africa, Ireland and New Zealand, doctors from around the world were able to pool their collective wisdom online to recommend options for follow up testing and treatment, saving the girls' life and potentially reducing the infection risk for others in her community.

Continue Reading
This image opens in the lightbox
SERMO E.Coli Infographic (PRNewsFoto/)

Photo - http://photos.prnewswire.com/prnh/20150807/256922-INFO
Logo - http://photos.prnewswire.com/prnh/20150113/169025LOGO

Dr. John Fernandes, a physician from Canada, posted the case of a four year old girl who tested positive for a deadly strain of E. coli, seeking advice on treatments and ways to find the source of contamination. Within just a few hours, a gastroenterologist from the United States, responded:

"You need to keep these patients in the hospital until they are better...Get CDC involved in tracing, you can't do that yourself. Do they eat out habitually? Salad bars, cold cut meats, salads etc.? You want to do everything to prevent intravascular dehydration."

A South African general practitioner shared more advice, recommending the treatment that ultimately cured the patient within 12 days:

"In your search for the contamination source, involve places visited, parties they went to etc. Keep the patient in hospital until they are well. Add probiotics to the treatment."

Since originally posting the case on July 1, 46 doctors from around the world, including nephrologists, pediatricians and more, responded. While the source of this child's infection remains unidentified, Dr. Fernandes followed the advice of his global peers and the girl's health returned to normal less than 2 weeks later. Dr. Fernandes also provided the parents with hygiene recommendations to reduce the spread of the illness.

"This is an amazing example of the power of medical crowdsourcing and international collaboration," said Dr. James Wilson, an American SERMO member and Ascel Bio infectious disease forecaster based out of the University of Nevada-Reno. "While most E. coli infections are not life-threatening, it's troubling and extremely concerning when an infectious illness claims a child's life so quickly and infects a younger sibling shortly after. It is especially important in cases like this that a physician acts quickly and exhausts all options and resources available to preserve life. This was also a great teaching moment for the U.S. physician audience as it drew attention to forecasts, which indicated the increased risk of E. coli-related complications, helping them avoid a similar preventable death."

"Allowing doctors to work effectively as teams seamlessly across borders is at the heart of our mission," said SERMO CEO Peter Kirk. "This is what SERMO is all about and I applaud all our physicians for contributing."

The E. coli case is just one example where medical crowdsourcing on SERMO saved a life. The posting of the case was not only life-saving for the patient but educational for doctors around the world. In addition to the 46 unique doctors participating in solving the case, the post was viewed by 1,253 doctors around the world.

A recent SERMO poll of over 1,350 physicians in seven countries explored the benefits of medical crowdsourcing among doctors and found the below ranked highest:

  • Solving tough patient cases like the Canadian doctor's case
  • Education on new medical techniques/approaches, and
  • Having a safe space to talk with other physicians.

To download the infographic with additional data and information about this patient case, please visit: http://www.sermo.com/who-we-are/media-materials#download.

On SERMO, doctors regularly benefit from the power of medical crowdsourcing to address the "grey zone," an unclear space where physicians have several clinical possibilities and must make a judgement call to solve the case. Over the course of 2014, doctors anonymously posted 3,500 challenging patient cases on the social network, which were viewed a total of 700,000 times and received 50,000 comments. On SERMO, most doctors receive responses from peers within 90 minutes and solve cases within 24 hours.

For more information about SERMO, its recent expansion into the UK, Australia, Canada, Ireland, New Zealand and South Africa, and solved patient cases, please go to www.sermo.com.   

About SERMO

SERMO is the leading social network for physicians - the virtual doctors' lounge and the home of medical crowdsourcing - where doctors anonymously share their true feelings about their profession and lives and talk 'real world' medicine. SERMO has nearly 400,000 fully verified and licensed members and is now available for doctors in seven countries: the US, UK, Canada, Australia, South Africa, Ireland and New Zealand. Founded in 2005, SERMO's mission is to unite physicians and provide them with a safe, private and trusted platform for free and open discussions. SERMO harnesses the collective wisdom of doctors, enabling medical crowdsourcing, knowledge sharing and thus the advancement of medicine.

Media Contacts:
Randi Kahn, Public Relations Manager, SERMO
randi.kahn@sermo.com; +1.212.358.0800 x967

Osnat Benshoshan, SVP, Marketing & Strategy, SERMO
osnat.benshoshan@sermo.com;

Victoria Khamsombath, SHIFT Communications
SERMO@shiftcomm.com; +1.415.591.8464

Related Links

http://www.sermo.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.